How the gum works
A specially engineered chewing gum has reduced oral HPV by up to 93 percent in a new study. The gum also nearly eliminated two bacteria linked to head and neck cancer. The findings were published this month and have drawn attention from cancer researchers.
HPV, or human papillomavirus, is one of the most common viruses passed through intimate contact. A growing share of head and neck cancers are linked to oral HPV infection. Most vaccines target HPV, but many adults were never vaccinated, and vaccine access remains uneven around the world.
Protecting beneficial mouth bacteria
The gum's design is what sets it apart. It targets the harmful virus and bacteria while leaving beneficial mouth bacteria intact. That matters, because a healthy balance of oral microbes helps protect against other infections.
Researchers said the gum could offer a safer and more affordable option than current approaches. It is designed for daily use, much like a regular chewing gum, which could make it easy for people to adopt.
Next steps toward a clinical product
The results come from early testing, and the authors caution that more work is needed. Clinical trials will be required to confirm the effects in larger groups and to check long-term safety.
If those trials succeed, the gum could become a low-cost prevention tool, especially in regions where HPV vaccines are hard to obtain. For now, the study adds a new and unusual candidate to the toolkit for fighting virus-linked cancers.